These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26049628)

  • 1. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
    Riella LV; Sheridan AM
    Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
    Tzur S; Rosset S; Skorecki K; Wasser WG
    Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should kidney donors be genotyped for APOL1 risk alleles?
    Freedman BI; Julian BA
    Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
    Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
    Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
    Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
    Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
    Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
    Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Ma L; Langefeld CD; Comeau ME; Bonomo JA; Rocco MV; Burkart JM; Divers J; Palmer ND; Hicks PJ; Bowden DW; Lea JP; Krisher JO; Clay MJ; Freedman BI
    Kidney Int; 2016 Aug; 90(2):389-395. PubMed ID: 27157696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.
    Gordon EJ; Amόrtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR
    Am J Kidney Dis; 2018 Dec; 72(6):819-833. PubMed ID: 30360961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 variants associate with increased risk of CKD among African Americans.
    Foster MC; Coresh J; Fornage M; Astor BC; Grams M; Franceschini N; Boerwinkle E; Parekh RS; Kao WH
    J Am Soc Nephrol; 2013 Sep; 24(9):1484-91. PubMed ID: 23766536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based risk assessment of APOL1 on renal disease.
    Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
    J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
    Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
    Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
    Mena-Gutierrez AM; Reeves-Daniel AM; Jay CL; Freedman BI
    Transplantation; 2020 Jan; 104(1):27-32. PubMed ID: 31449181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein L1 Gene Effects on Kidney Transplantation.
    Freedman BI; Locke JE; Reeves-Daniel AM; Julian BA
    Semin Nephrol; 2017 Nov; 37(6):530-537. PubMed ID: 29110760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI; Shaw AS; Hruska KA; Jain S
    Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.